Randomized Phase 1/2 Open-Label Trial of PR104 and Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)
Condition(s):Hepatocellular CarcinomaLast Updated:August 23, 2013Terminated
Hide Studies Not Open or Pending
Condition(s):Hepatocellular CarcinomaLast Updated:August 23, 2013Terminated
Condition(s):Leukemia; Myelodysplastic SyndromeLast Updated:July 16, 2012Terminated
Condition(s):Thrombosis; Acute Coronary Syndrome; Myocardial Infarction; StrokeLast Updated:October 19, 2012Completed
Condition(s):Chronic Myelogenous LeukemiaLast Updated:March 4, 2014Withdrawn
Condition(s):Lung CancerLast Updated:December 10, 2012Terminated
Condition(s):Unspecified Adult Solid Tumor, Protocol SpecificLast Updated:June 16, 2014Terminated
Condition(s):Unspecified Adult Solid Tumor, Protocol SpecificLast Updated:May 24, 2011Completed
Condition(s):Unspecified Adult Solid Tumor, Protocol SpecificLast Updated:June 1, 2011Completed
Condition(s):Methamphetamine Dependence; Cocaine DependenceLast Updated:October 7, 2014Completed
Condition(s):Parkinson DiseaseLast Updated:January 18, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.